AHCJ member Laura Newman, the About.com guide to urology, writes about whether consumers will embrace the message that “‘less is more,’ when science confirms it.” In this case, Newman focuses on the American Urological Association’s guideline for kidney cancer treatment, released in April, that called for saving the kidney whenever possible.
Taken in the context of the conflicts in the past few weeks over recommendations for less PSA screening, less breast cancer screening, and less cervical cancer screening, I commend the AUA and other physician organizations for reviewing the balance of benefits and harms in treating early-stage kidney cancer more aggressively.
